-transparent.png){kind=logo}
In rare cases, acromegalic patients have normal basal concentrations of growth hormone, and their acromegaly results from abnormal growth-hormone secretory patterns. A patient is reported with the clinical features of acromegaly, who had elevated somatomedin levels and an enlarged sella turcica, but whose serum growth-hormone levels on continuous monitoring were in the normal range, with levels of 2.8 to 8.9 ng/ml. Dynamic studies of growth hormone revealed normal responses to hypo- and hyperglycemia, but abnormal responses to L-dopa and thyroid-releasing hormone. At surgery, neither a pituitary adenoma nor eosinophilic hyperplasia was present. It is likely that this patient's acromegaly resulted from the presence of chronically high normal levels of growth hormone.
K R Feingold, and
I D Goldfine, and
P R Weinstein
January 1985,
The Western journal of medicine,
K R Feingold, and
I D Goldfine, and
P R Weinstein
August 1997,
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
K R Feingold, and
I D Goldfine, and
P R Weinstein
May 2000,
Pituitary,
K R Feingold, and
I D Goldfine, and
P R Weinstein
January 2023,
Surgical neurology international,
K R Feingold, and
I D Goldfine, and
P R Weinstein
September 1978,
Annals of internal medicine,
K R Feingold, and
I D Goldfine, and
P R Weinstein
December 1969,
British medical journal,
K R Feingold, and
I D Goldfine, and
P R Weinstein
January 1982,
Acta medica Scandinavica,
K R Feingold, and
I D Goldfine, and
P R Weinstein
December 1974,
Annals of internal medicine,
K R Feingold, and
I D Goldfine, and
P R Weinstein
May 1974,
MMW, Munchener medizinische Wochenschrift,
K R Feingold, and
I D Goldfine, and
P R Weinstein
September 1965,
Lancet (London, England),
